Pharmaceuticals MD $25K – $100K Expired Reviewed

Amyloid radiotracers for Baltimore Longitudinal Study of Aging

HHS

Bethesda, MD

amyloid radiotracers PET imaging agents Alzheimer's diagnostics $25K – $100K

Posted Aug 26, 2026

Closed Aug 31, 2026

Description

The National Institutes of Health seeks to procure sixty-two amyloid radiotracers for use in the Baltimore Longitudinal Study of Aging. This non-competitive solicitation is directed solely to Progenics Pharmaceuticals Inc. to maintain scientific continuity. Firms specializing in radiopharmaceuticals and amyloid imaging agents would normally be qualified to respond to similar requirements.

A strong match for healthcare vendors

Curated for medical & healthcare suppliers

Why we classified this as medical

Title and description explicitly request 62 (plus optional 80) amyloid radiotracers from Progenics Pharmaceuticals for the Baltimore Longitudinal Study of Aging; these are radiopharmaceuticals used in PET imaging for clinical research on Alzheimer's and aging.

View Original Source

Save for Later

Send to Pipeline